142 related articles for article (PubMed ID: 33356062)
1. Analysis of novel serum markers of fibrosis and angiogenesis in patients with alcoholic liver cirrhosis.
Prystupa A; Kiciński P; Luchowska-Kocot D; Nowicki G; Dzida G; Myśliński W; Zakrzewski M; Mosiewicz J; Panasiuk L
Ann Agric Environ Med; 2020 Dec; 27(4):568-573. PubMed ID: 33356062
[TBL] [Abstract][Full Text] [Related]
2. Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.
Prystupa A; Boguszewska-Czubara A; Bojarska-Junak A; Toruń-Jurkowska A; Roliński J; Załuska W
Ann Agric Environ Med; 2015; 22(2):325-8. PubMed ID: 26094532
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing serum chemerin and kallistatin concentrations in patients with alcohol-induced liver cirrhosis.
Prystupa A; Kiciński P; Luchowska-Kocot D; Sak J; Prystupa TK; Tan YH; Panasiuk L; Załuska W
Ann Agric Environ Med; 2019 Mar; 26(1):143-147. PubMed ID: 30922045
[TBL] [Abstract][Full Text] [Related]
4. Afamin and adropin in patients with alcohol-induced liver cirrhosis.
Prystupa A; Kiciński P; Luchowska-Kocot D; Sak J; Prystupa T; Chen KH; Chen YC; Panasiuk L; Załuska W
Ann Agric Environ Med; 2018 Sep; 25(3):527-531. PubMed ID: 30260179
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Impact of Preoperative Values of Hyaluronic Acid and Type IV Collagen on the Outcome of Patients with Hepatocellular Carcinoma After Hepatectomy.
Ueda J; Yoshida H; Mamada Y; Taniai N; Yoshioka M; Hirakata A; Kawano Y; Shimizu T; Kanda T; Takata H; Uchida E
J Nippon Med Sch; 2018; 85(4):221-227. PubMed ID: 30259891
[TBL] [Abstract][Full Text] [Related]
6. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
7. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
[TBL] [Abstract][Full Text] [Related]
8. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
9. Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial.
Vanlemmens C; Di Martino V; Milan C; Messner M; Minello A; Duvoux C; Poynard T; Perarnau JM; Piquet MA; Pageaux GP; Dharancy S; Silvain C; Hillaire S; Thiefin G; Vinel JP; Hillon P; Collin E; Mantion G; Miguet JP;
Ann Intern Med; 2009 Feb; 150(3):153-61. PubMed ID: 19189904
[TBL] [Abstract][Full Text] [Related]
10. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
El-Shal AS; Zidan HE; Rashad NM; Wadea FM
Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
[TBL] [Abstract][Full Text] [Related]
13. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
14. PDGF-BB homodimer serum level - a good indicator of the severity of alcoholic liver cirrhosis.
Kurys-Denis E; Prystupa A; Luchowska-Kocot D; Krupski W; Bis-Wencel H; Panasiuk L
Ann Agric Environ Med; 2020 Mar; 27(1):80-85. PubMed ID: 32208584
[TBL] [Abstract][Full Text] [Related]
15. Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis.
Hilgard P; Schreiter T; Stockert RJ; Gerken G; Treichel U
Hepatology; 2004 May; 39(5):1398-407. PubMed ID: 15122769
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress-induced growth inhibitor 1 in alcohol-induced liver cirrhosis.
Sak JJ; Prystupa A; Bis-Wencel H; Kiciński P; Luchowska-Kocot D; Krukowski H; Nowicki GJ; Panasiuk L
Ann Agric Environ Med; 2021 Dec; 28(4):676-680. PubMed ID: 34969228
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
18. Performance of autotaxin as a serum marker for liver fibrosis.
Ikeda H; Kobayashi M; Kumada H; Enooku K; Koike K; Kurano M; Sato M; Nojiri T; Kobayashi T; Ohkawa R; Shimamoto S; Igarashi K; Aoki J; Yatomi Y
Ann Clin Biochem; 2018 Jul; 55(4):469-477. PubMed ID: 29065699
[TBL] [Abstract][Full Text] [Related]
19. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
[TBL] [Abstract][Full Text] [Related]
20. Selected Noninvasive Markers in Diagnosing Liver Diseases.
Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Świderska M; Flisiak R; Szmitkowski M; Chrostek L
Lab Med; 2016 Feb; 47(1):67-72. PubMed ID: 26715612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
